(RT-CAS 2381089-83-2)
Triple receptor agonist (GIP, GLP-1, Glucagon) for metabolic pathway research
Key Features & Research Applications
- Triple receptor engagement (GIP + GLP-1 + Glucagon): Enables comprehensive investigation of incretin and glucagon pathways for glucose and energy metabolism in vitro/preclinical models.
- Engineered stability: Incorporates structural modifications for extended half-life and albumin binding in research contexts
- Lab-friendly format: Supplied lyophilized; recommended storage at –20 °C, protected from light/moisture; solubility references include DMSO for stock solutions under appropriate lab protocols.
- Metabolic research models: Suitable for receptor-binding studies, pathway mapping, and comparative analyses versus single- or dual-agonist compounds.
Technical Specifications
| Attribute | Details |
|---|---|
| CAS Number | 2381089-83-2 |
| Molecular Formula | C₂₃₀H₃₆₀N₅₀O₆₈ |
| Molecular Weight | ~4,900 Da |
| Sequence (overview) | 39-aa peptide; includes modifications for stability and albumin binding |
| Form | Lyophilized powder (research grade) |
| Storage | –20 °C; dry, protected from light/moisture |
| Solubility | Soluble in DMSO; aqueous buffers for working solutions |
| Intended Use | Research use only—not for human/veterinary use, diagnostic, or therapeutic applications |
- FAQ
- Is this product intended for human use?
No. It is for research use only—not for human or veterinary applications. - How should it be stored?
Store lyophilized vials at –20 °C, protected from light and moisture, and follow your lab’s SOPs and the product COA. - What solvents are referenced?
References indicate solubility in DMSO; working solutions may use appropriate buffers per lab protocols.
